Find Paper, Faster
Example:10.1021/acsami.1c06204 or Chem. Rev., 2007, 107, 2411-2502
Immune responses to COVID-19 vaccines in patients with cancer: Promising results and a note of caution
Cancer Cell  (IF31.743),  Pub Date : 2021-07-03, DOI: 10.1016/j.ccell.2021.07.001
Elizabeth A. Griffiths, Brahm H. Segal

SARS-CoV-2 vaccines are effective in preventing COVID-19. Patients with cancer are at high risk for severe COVID-19 and are appropriately prioritized for vaccination. Several studies in this issue of Cancer Cell add to our knowledge of the heterogeneity of immune responses to vaccination among patients with cancer and identify important areas for future research.